1 min left

0% read

OurCrowd

Finance

Software

Technology Company

Jerusalem, Israel

Founded 2013

OurCrowd was founded on the idea that startup development becomes more successful when the global "crowd" has access to VC-level funding opportunities. It is the most active venture investor in Israel, which evaluates and chooses businesses, invests funds, and gives its worldwide network. International businesses, businesspeople, investors, venture capitalists, and institutions from around the world are all part of their extensive worldwide network.

Company Details

Founder & CEO: Jonathan Medved
Founded: February 2013
Headquarters: Jerusalem, Israel

Key Features

Allows institutions and private investors to participate in and support startup businesses.

Offers guidance and enlists the help of industry advisors to create value for its portfolio firms.

Provides advice and connects startups to important networks to support their growth.

Allows users to find, track, and manage investments conveniently with its easy-to-navigate platform.

Frequently Asked Questions About OurCrowd

OurCrowd is a company in the cryptocurrency and blockchain space. Visit their profile on Crypto News Navigator for details about their services, team, and company background.

OurCrowd was founded on the idea that startup development becomes more successful.

OurCrowd has been operating since 2013. You can verify their legitimacy through their official website and social media presence.

OurCrowd operates in the finance sector of the cryptocurrency industry. Compare OurCrowd with other finance companies on Crypto News Navigator to evaluate services, features, and reputation before making your decision.

Before using OurCrowd, research their track record (operating since 2013), verify their regulatory compliance, read user reviews, and understand their fee structure. Never share your private keys with any service, and start with small amounts until you are comfortable with the platform.

Safety depends on multiple factors including regulatory compliance, security practices, and track record. OurCrowd is based in Jerusalem, Israel, has been operating since 2013. Always enable two-factor authentication, use strong passwords, and never store large amounts on any third-party platform.

OurCrowd is based in Jerusalem, Israel.

OurCrowd was founded in 2013.

OurCrowd Details

OurCrowd Tags

Latest from Academy

Altcoins

BLAST

APT

NPC

Blast Ecosystem Grew 400% in Six Months and Nobody Talked About It

The Blast ecosystem has been crypto's most misunderstood narrative of 2026. While the market fixated on a 98.3% drawdown from all-time highs, less-publicized on-chain data tells a counterintuitive story. Three major protocol upgrades shipped since January 2025, 10% TVL growth appeared week-on-week in April, and 279,520 holders remain HODLing their positions on a chain the world has given up on.

Crypto News NavigatorApr 26, 2026

7m read

Altcoins

LON

VET

HOME

Why Tokenlon's Revenue Doesn't Match Its Token Price

DEX aggregation is "solved" in DeFi, right? 1inch, Jupiter, Paraswap have you covered. Except the data paints a different picture. Tokenlon quietly processes over $120 million in weekly trading volume and a 99.71% order success rate, yet remains shockingly absent from discussion in industry forums and panels. Either the market is correct and Tokenlon's fundamentals are not what we perceive, or a highly-traveled protocol has been willfully ignored.

Mia HallandApr 26, 2026

8m read

Trading Analysis

BIO

CHZ

COW

Sixty-Five Million in BioDAOs, BIO at One Cent

Bio Protocol's CEO recently revealed that PeptAI designed a new ADHD peptide candidate in 24 hours for roughly $1,500 in initial lab validation. While crypto traders focus on memecoins, Bio Protocol has quietly built a scientific funding platform backed by Pfizer Ventures, Binance Labs, and Arthur Hayes' Maelstrom Fund. The bio price trades at $0.031, down 96.5% from its all-time high of $0.889, despite $65M in combined BioDAO research funding and active clinical trials.

Katerina KulikovskaApr 25, 2026

8m read